盘前交易 07:13 (美东)1.750USD+0.020+1.16%关键数据
1.770今开
1.860最高
773.78K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.10%换手率
1.750昨收
1.710最低
1.39M成交额
亏损市盈率静
1.19市净率
0.00%股息率 TTM
-10.69%ROA
1.83052周最高
0.24量比
-53.22M净利润
746.33M总股本
-0.2721每股收益TTM
1.47Beta
-16.92%ROE
0.98052周最低
10.57%振幅
39.14%毛利率
1.29B总市值
5.34回报/风险
3.62%风险率

即将为您带来更多新闻,敬请期待。。。
OPKO Health Inc评分
-0.50与上次评分对比预测7.67
财务诊断5.59
技术分析5.34
公司估值8.43
机构认同度3.00
风险评估5.27
分析师评级
买入评级
3.950目标均价
+137.95%涨幅空间
OPKO Health Inc 最新财报电话会记录
OPKO Health (OPK) 2026年第三季度财报电话会:7.22亿美元LabCorp交易重塑业务
OPKO Health 2026年第三季度业绩电话会:营收增长16%至6540万美元,而与LabCorp达成的7.22亿美元交易正推动其向专注的生物技术公司转型。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
OPKO Health Inc 简介
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
行业医疗服务供应商
公司代码OPK
员工数量2997
国家
持股情况
| 持股股东 | 占比 |
|---|
| Frost Gamma Investments Trust | 28.70% |
|---|
| Rubric Capital Management LP | 6.33% |
|---|
| Holbrook (Bruce C) | 5.35% |
|---|
| Hsiao (Jane H) | 4.39% |
|---|
| 股东类型 | 占比 |
|---|
| Corporation | 38.33% |
|---|
| Investment Advisor | 12.75% |
|---|
| Individual Investor | 11.15% |
|---|
| Hedge Fund | 7.72% |
|---|
常见问题
OPKO Health Inc(OPK)的当前股价是多少?
OPKO Health Inc(OPK)的当前股价是 1.73。
OPKO Health Inc的股票代码是什么?
OPKO Health Inc的股票代码是OPK。
OPKO Health Inc股票的52周最高点是多少?
OPKO Health Inc股票的52周最高点是1.83。
OPKO Health Inc股票的52周最低点是多少?
OPKO Health Inc股票的52周最低点是0.98。
OPKO Health Inc的市值是1.29B。
现在OPKO Health Inc(OPK)的股票是买入、持有还是卖出?
根据分析师评级,OPKO Health Inc(OPK)的总体评级为买入,目标价格为3.95。
OPKO Health Inc(OPK)股票的每股收益(EPS TTM)是多少
OPKO Health Inc(OPK)股票的每股收益(EPS TTM)是-0.27。